美國的電氣生理學藍圖·切除設備市場:2012年

美國的電氣生理學(EP)藍圖及切除設備市場呈現強力的成長。心房纖維顫動(AF)導管切除的治療數的增加等作為主要促進因素。人口結構的變化，醫生的AF治療的實行能力的提高，抗心律不整藥的非有效性，患者間的治療可供選擇的導管切除的認識度的提高等皆促進AF治療數的增加。

本報告提供電氣生理學藍圖·切除整體市場概要與預測，以及實驗室系統，診斷導管，關於導管消融術等的市場概要與趨勢，市場預測，競爭環境等等詳細檢驗，為您概述為以下內容。

摘要整理

調查手法

第1章 臨床情形

• 背景
  • 心律不整
• 診斷與介紹趨勢
• 治療概要
  • 導管切除
  • 混合消融術
  • 治療方法的競爭
• 臨床指南
• 國家概要
  • 人口統計與經濟
  • 醫療系統
  • 法規環境

第2章 產品

• 概要
• 電氣生理學實驗室系統
• 電氣生理學診斷導管
• 電氣生理學導管消融術

第3章 臨床實驗

• 完成的臨床實驗
• 進行中的臨床實驗

第4章 品牌及競爭分析

• 概要
  • 競爭的概要
  • 詳細的競爭情形
  • 市場佔有率
  • 最近的事項
• 電氣生理學實驗室系統市場
  • 競爭的概要
  • 市場佔有率
• 電氣生理學診斷導管市場
  • 競爭的概要
  • 市場佔有率
• 電氣生理學導管消融術市場
  • 競爭的概要
  • 市場佔有率

第5章 市場預測

• 概要
  • 市場概要
  • 詳細的市場情況
• 電氣生理學實驗室系統市場
  • 市場概要
  • 詳細的市場情況
• 電氣生理學診斷導管市場
  • 市場概要
  • 詳細的市場情況
• 電氣生理學導管消融術市場
  • 市場概要
  • 詳細的市場情況

附錄

圖表

The US electrophysiology (EP) mapping and ablation device market is experiencing strong growth, primarily due to the increase in atrial fibrillation (AF) catheter ablation procedure volumes. Growth in AF procedure volumes is in turn driven by changing demographics, increasing physician confidence and ability in performing AF procedures, the relative ineffectiveness of antiarrhythmic drugs in this indication, and increasing patient awareness of catheter ablation as a treatment option. Growth in AF procedure volumes supports revenue growth because the catheter ablation treatment of AF typically involves more advanced devices, such as loop and/or ultrasound diagnostic catheters, which are sold at a premium price. Nonetheless, the major limiters in this market, including alternative treatments and constrained health care budgets, are relatively stable factors that will persist throughout the forecast period. Device reprocessing will also hinder sales in the EP diagnostic catheter market specifically. Despite these limiting factors, the EP mapping and ablation device market will continue to grow with the release of premium-priced innovations that increase safety, decrease procedure times, and improve success rates.

This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include

• government publications, such as documentation from securities commissions, health care and statistical agencies, and regulatory and patent authorities;
• material provided by medical technology companies, including annual reports, product brochures, and corporate profiles;
• internal databases and reports, including previous reports on similar or related topics; and
• general Internet searches, medical literature, and newspaper and magazine searches to identify various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is either discarded or marked as high- or low-priority and then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes - unit sales, ASPs, and revenues - as well as market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research phase, industry and medical experts are identified. These experts are then contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of each particular interviewee, although in most cases, the most important questions are asked of all experts.

The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then augmented, discarded, or adjusted based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and to reach positions of consensus on issues and market numbers.

In some cases, a sample of relevant physicians is surveyed or interviewed. Physicians are asked to comment on various issues and trends, both in their own practice and in the overall market. The responses provided are then used to strengthen or augment the assumptions and hypotheses developed during the primary research phase.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

Millennium Research Group's Marketrack methodology involves recruiting hospital personnel responsible for the management of medical equipment and procedures to participate by providing procedure volumes, device usage data, and brand-level pricing information on an ongoing basis.

Hospital respondents include facility managers, nurses, administrators, and physicians. Information is generally collected on a quarterly basis and includes, but is not limited to, numbers and types of procedures performed and devices used.

In addition to the research methodology outlined above, the following “bottom-up” methodology is used to develop forecast assumptions for the report.

A comprehensive breakdown of various procedures and device unit sales is prepared using data from several sources, including professional associations, government statistics, and private research/media sources. Industry experts and practitioners are consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through annual reports and other sources are compared against modeled industry revenues.

Using the best estimates of industry experts, practitioners, private research/media sources, and inhouse experts, year-by-year growth rates and ASPs are applied individually to each subcategory to derive forecasts. These estimates are cross-checked by industry experts (marketing managers, product managers, company executives, etc.) and further refined.

Overall findings are compared against market and procedure forecasts published by other sources to ensure reasonable estimates.

Companies mentioned in this report:

• Ablation Frontiers (a division of Medtronic)
• Advanced Cardiac Therapeutics
• Biosense Webster
• BIOTRONIK
• Boston Scientific
• CardioFocus
• Catheter Robotics
• C. R. Bard
• CryoCath (a division of Medtronic)
• Endosense
• GE Healthcare
• Hansen Medical
• Imricor Medical Systems
• Magnetecs
• Medtronic
• MRI Interventions
• Omega Medical Imaging
• Philips Healthcare
• Rhythmia Medical
• Shimadzu
• Siemens Healthcare
• Stereotaxis
• St. Jude Medical
• Topera Medical
• Toshiba Medical Systems
• Voyage Medical

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

1. CLINICAL LANDSCAPE

• 1.1. Background
  • 1.1.1. Arrhythmias
    • 1.1.1.1. Atrial Fibrillation
    • 1.1.1.2. Atrioventricular Nodal Reentry Tachycardia
    • 1.1.1.3. Wolff-Parkinson-White Syndrome
    • 1.1.1.4. Atrial Flutter
    • 1.1.1.5. Atrial Tachycardia
    • 1.1.1.6. Ventricular Tachycardia
• 1.2. Diagnosis and Referral Patterns
• 1.3. Procedure Overview
  • 1.3.1. Catheter Ablations
  • 1.3.2. Hybrid Ablations
  • 1.3.3. Competing Treatments
    • 1.3.3.1. Medical Management
    • 1.3.3.2. Surgical Ablation
    • 1.3.3.3. Device Implantation
• 1.4. Clinical Guidelines
• 1.5. Country Overview
  • 1.5.1. Demographics and Economy
  • 1.5.2. Health Care System
  • 1.5.3. Regulatory Environment

2. PRODUCTS

• 2.1. Overview
  • 2.1.1. Products Covered
• 2.2. Electrophysiology Lab Systems
  • 2.2.1. Functions
  • 2.2.2. Differentiating Features
  • 2.2.3. Labeled Indications
  • 2.2.4. Emerging Products
• 2.3. Electrophysiology Diagnostic Catheters
  • 2.3.1. Functions
  • 2.3.2. Differentiating Features
  • 2.3.3. Labeled Indications
  • 2.3.4. Emerging Products
• 2.4. Electrophysiology Ablation Catheters
  • 2.4.1. Functions
  • 2.4.2. Differentiating Features
  • 2.4.3. Labeled Indications
  • 2.4.4. Emerging Products

3. CLINICAL TRIALS

• 3.1. Completed Clinical Trials
  • 3.1.1. Device-Specific Trials
  • 3.1.2. Procedure-Specific Trials
• 3.2. Ongoing Clinical Trials
  • 3.2.1. Device-Specific Trials
  • 3.2.2. Procedure-Specific Trials
    • 3.2.2.1. Ablation Trials
    • 3.2.2.2. Hybrid Procedure Trials

4. BRANDS AND COMPETITIVE ANALYSIS

• 4.1. Overview
  • 4.1.1. Competitive Snapshot
  • 4.1.2. Detailed Competitive Landscape
  • 4.1.3. Market Shares
  • 4.1.4. Recent Events
• 4.2. Electrophysiology Lab System Market
  • 4.2.1. Competitive Snapshot
  • 4.2.2. Market Shares
• 4.3. Electrophysiology Diagnostic Catheter Market
  • 4.3.1. Competitive Snapshot
  • 4.3.2. Market Shares
• 4.4. Electrophysiology Ablation Catheter Market
  • 4.4.1. Competitive Snapshot
  • 4.4.2. Market Shares

5. MARKET OUTLOOK

• 5.1. Overview
  • 5.1.1. Market Snapshot
  • 5.1.2. Detailed Market Overview
• 5.2. Electrophysiology Lab System Market
  • 5.2.1. Market Snapshot
  • 5.2.2. Detailed Market Overview
• 5.3. Electrophysiology Diagnostic Catheter Market
  • 5.3.1. Market Snapshot
  • 5.3.2. Detailed Market Overview
• 5.4. Electrophysiology Ablation Catheter Market
  • 5.4.1. Market Snapshot
  • 5.4.2. Detailed Market Overview

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

• Figure 1: EP Mapping and Ablation Device Market, by Product Type, US (USD), 2010 - 2016
• Table 1: EP Mapping and Ablation Device Market Landscape, US (USD), 2011 and 2016
• Table 2: EP Mapping and Ablation Device Market Leaders, by Product Type and Revenue, US, 2011
• Table 3: Most Promising Emerging Technologies in the EP Mapping and Ablation Device Market, US, 2011 - 2016
• Table 4: Expected Key Events in the EP Mapping and Ablation Device Market, US, 2012 - 2016
• Table 5: Factors Impacting the EP Mapping and Ablation Device Market, by Product Type, US, 2011 - 2016
• Table 6: Companies Mentioned in This Report

1. CLINICAL LANDSCAPE

• Table 7: Treatment Providers and Referral Patterns, by Treatment Phase
• Table 8: EP Catheter Procedures
• Table 9: EP Mapping and Ablation Treatment Guidelines
• Table 10: Key Health and Economic Indicators, US

2. PRODUCTS

• Table 11: EP Mapping and Ablation Device Market, by Product Type, US
• Table 12: EP Lab System Functions, by Product Type
• Table 13: Typical Lab System Life Spans, by Product Type
• Table 14: Advantages and Disadvantages of EP Lab Systems, by Product Type
• Table 15: Emerging Products in Development for the EP Lab System Market, US, 2011 - 2016
• Table 16: EP Diagnostic Catheter Functions, by Product Type and Product Feature
• Table 17: Advantages and Disadvantages of EP Diagnostic Catheters, by Product Type and Product Feature
• Table 18: Emerging Products in Development for the EP Diagnostic Catheter Market, US, 2011 - 2016
• Table 19: EP Ablation Catheter Functions, by Product Type and Product Feature
• Table 20: Advantages and Disadvantages of EP Ablation Catheters, by Product Type and Product Feature
• Table 21: Advantages and Disadvantages of Irrigated-Tip RF Ablation Catheters, by Product Feature
• Table 22: Ablation Catheters Approved for the Treatment of AF, US, 2011
• Table 23: Emerging Products in Development for the EP Ablation Catheter Market, US, 2011 - 2016

3. CLINICAL TRIALS

• Table 24: Summary of Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right- Sided Electrophysiology Mapping Studies
• Table 25: Summary of EAS-AC
• Table 26: Summary of RICTAM
• Table 27: Summary of EZCF-125
• Table 28: Summary of STOP-AF
• Table 29: Summary of RAAFT
• Table 30: Summary of CABANA Pilot Trial
• Table 31: Summary of APAF 2
• Table 32: Summary of ARTISAN-AF
• Table 33: Summary of CLARITY-AF
• Table 34: Summary of BLOCk-CTI
• Table 35: Summary of the ThermoCool SmartTouch Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation Trial
• Table 36: Summary of TOCCASTAR
• Table 37: Summary of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF) Trial
• Table 38: Summary of DISCERN-AF
• Table 39: Summary of FAST II
• Table 40: Summary of ERASE-VT
• Table 41: Summary of MANTRA-PAF
• Table 42: Summary of CASTLE-AF
• Table 43: Summary of CABANA
• Table 44: Summary of EAST
• Table 45: Summary of DEEP
• Table 46: Summary of Atrial Fibrillation Ablation The Hybrid Approach Versus Traditional Management (AF)

4. BRANDS AND COMPETITIVE ANALYSIS

• Figure 2: Leading Competitors in the EP Mapping and Ablation Device Market, as a % of Total, US, 2011
• Table 47: Leading Competitors in the EP Mapping and Ablation Device Market, by Product Type, as a % of Total, US, 2011
• Table 48: Recent Events in the EP Mapping and Ablation Device Market, US
• Figure 3: Leading Competitors in the EP Lab System Market, as a % of Total, US, 2011
• Table 49: Leading Competitors in the EP Lab System Market, by Product Type, as a % of Total, US, 2011
• Figure 4: Leading Competitors in the OEM EP Diagnostic Catheter Market, as a % of Total, US, 2011
• Table 50: Leading Competitors in the OEM EP Diagnostic Catheter Market, by Product Type, as a % of Total, US, 2011
• Table 51: Leading Competitors in the OEM Conventional EP Diagnostic Catheter Market, by Product Feature, as a % of Total, US, 2011
• Table 52: Leading Competitors in the OEM Advanced EP Diagnostic Catheter Market, by Product Feature, as a % of Total, US, 2011
• Figure 5: Leading Competitors in the EP Ablation Catheter Market, as a % of Total, US, 2011
• Table 53: Leading Competitors in the EP Ablation Catheter Market, by Product Type, as a % of Total, US, 2011
• Table 54: Leading Competitors in the EP RF Ablation Catheter Market, by Product Feature, as a % of Total, US, 2011

5. MARKET OUTLOOK

• Figure 6: EP Mapping and Ablation Device Market, by Product Type, US (USD), 2010 - 2016
• Figure 7: EP Mapping and Ablation Device Market, by Product Type, US (USD), 2010 - 2016
• Table 55: Factors Impacting the EP Mapping and Ablation Device Market, by Product Type, US, 2011 - 2016
• Table 56: Prevalence of AF, US, 2011 and 2016
• Table 57: EP Mapping and Ablation Device Market, by Product Type, US (USD), 2010 - 2016
• Figure 8: EP Lab System Market, by Product Type, US (USD), 2010 - 2016
• Figure 9: EP Lab System Market, by Product Type, as a % of Total, US, 2010 - 2016
• Table 58: EP Lab System Installed Base, by Product Type, US, 2010 - 2016
• Table 59: EP Lab System Penetration, by Facility Type, US, 2010 - 2016
• Table 60: EP Recording-Capable Lab System Penetration, by Facility Type, US, 2010 - 2016
• Table 61: EP Lab System Market, by Product Type, US (USD), 2010 - 2016
• Table 62: X-Ray System Market, US (USD), 2010 - 2016
• Table 63: 3-D Mapping System Market, US (USD), 2010 - 2016
• Table 64: EP Recording System Market, US (USD), 2010 - 2016
• Table 65: Remote Steering System Market, US (USD), 2010 - 2016
• Table 66: ICE System Market, US (USD), 2010 - 2016
• Table 67: RF Ablation Generator Market, US (USD), 2010 - 2016
• Figure 10: EP Diagnostic Catheter Market, by Product Type, as a % of Total, US, 2011 and 2016
• Figure 11: EP Diagnostic Catheter Market, by Product Type, US (USD), 2010 - 2016
• Table 68: EP Diagnostic Catheter Procedures, by Procedure Type, US, 2010 - 2016
• Table 69: EP Diagnostic Catheter Market, by Product Type, US (USD), 2010 - 2016
• Table 70: EP Diagnostic Catheter Market, by Origin, US (USD), 2010 - 2016
• Table 71: OEM EP Diagnostic Catheter Market, by Product Type, US (USD), 2010 - 2016
• Table 72: Reprocessed EP Diagnostic Catheter Market, by Product Type, US (USD), 2010 - 2016
• Table 73: Conventional Diagnostic Catheter Market, by Product Type, US (USD), 2010 - 2016
• Table 74: OEM Conventional Diagnostic Catheter Market, by Product Feature, US (USD), 2010 - 2016
• Table 75: Reprocessed Conventional Diagnostic Catheter Market, by Product Feature, US (USD), 2010 - 2016
• Table 76: Fixed Conventional Diagnostic Catheter Market, by Origin, US (USD), 2010 - 2016
• Table 77: Fixed Conventional Diagnostic Catheter Market Growth, by Origin, US, 2011 - 2016
• Table 78: Fixed Conventional Diagnostic Catheter Market, by Origin, as a % of Total, US, 2010 - 2016
• Table 79: Steerable Conventional Diagnostic Catheter Market, by Origin, US (USD), 2010 - 2016
• Table 80: Steerable Conventional Diagnostic Catheter Market Growth, by Origin, US, 2011 - 2016
• Table 81: Steerable Conventional Diagnostic Catheter Market, by Origin, as a % of Total, US, 2010 - 2016
• Table 82: Advanced Diagnostic Catheter Market, by Product Feature, US (USD), 2010 - 2016
• Table 83: OEM Advanced Diagnostic Catheter Market, by Product Feature, US (USD), 2010 - 2016
• Table 84: Reprocessed Advanced Diagnostic Catheter Market, by Product Feature, US (USD), 2010 - 2016
• Table 85: Loop Advanced Diagnostic Catheter Market, by Origin, US (USD), 2010 - 2016
• Table 86: Loop Advanced Diagnostic Catheter Market Growth, by Origin, US, 2011 - 2016
• Table 87: Loop Advanced Diagnostic Catheter Market, by Origin, as a % of Total, US, 2010 - 2016
• Table 88: Other Advanced Diagnostic Catheter Market, by Origin, US (USD), 2010 - 2016
• Table 89: Other Advanced Diagnostic Catheter Market Growth, by Origin, US, 2011 - 2016
• Table 90: Other Advanced Diagnostic Catheter Market, by Origin, as a % of Total, US, 2010 - 2016
• Table 91: Ultrasound Diagnostic Catheter Market, by Origin, US (USD), 2010 - 2016
• Table 92: Ultrasound Diagnostic Catheter Market Growth, by Origin, US, 2011 - 2016
• Table 93: Ultrasound Diagnostic Catheter Market, by Origin, as a % of Total, US, 2010 - 2016
• Figure 12: EP Ablation Catheter Market, by Product Type, as a % of Total, US, 2010 - 2016
• Figure 13: EP Ablation Catheter Market, by Product Type, US (USD), 2010 - 2016
• Table 94: EP Ablation Catheter Procedures, by Indication, US, 2010 - 2016
• Table 95: EP Ablation Catheter Procedures, by Product Type, US, 2010 - 2016
• Table 96: RF Ablation Catheter Procedures, by Product Feature, US, 2010 - 2016
• Table 97: EP Ablation Catheter Procedures, by Technique, US, 2010 - 2016
• Table 98: EP Ablation Catheter Market, by Product Type, US (USD), 2010 - 2016
• Table 99: RF Ablation Catheter Market, by Product Feature, US (USD), 2010 - 2016
• Table 100: RF Ablation Catheter Market Growth, by Product Feature, US, 2011 - 2016
• Table 101: RF Ablation Catheter Market, by Product Feature, as a % of Total, US, 2010 - 2016
• Table 102: Cryoablation Catheter Market, US (USD), 2010 - 2016
• Table 103: Navigational Accessory Market, US (USD), 2010 - 2016

APPENDIX: METHODOLOGY

• Table 104: ICD-9-CM Procedure Codes and Descriptions

APPENDIX: ACRONYMS AND INITIALISMS

• Table 105: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

美國電流生理學的映射•燒灼設備市場強力地成長